検索結果

Presence of Products | Overseas Activities | SENJU Pharmaceutical

Name Marketing Authorisation Holder JP Brand Name YELLOX Bausch + Lomb Poland Sp. z o.o. BRONUCK Netherland Brand Name Marketing Authorisation Holder JP Brand Name YELLOX Bausch + Lomb Poland Sp. z o...

千寿製薬株式会社

NEWS & RELEASE December 22, 2025 Obtained manufacturing and marketing approval in Japan for Avarept® Ophthalmic suspension 0.3%, a novel treatment of Dry Eye Disease through Transient Receptor Pot

R&D Pipeline | Research & Development | SENJU Pharmaceutica

PROGRESS OF DEVELOPMENT Disclosuring of information after Phase 1 DrugIndicationStatus (Region) SJP-0132Dry eyeApproval（Japan） PranoprofeninflammationApplication under review (Vietnam) SJP-0132Dry eye

Data And Statistics | About Senju | SENJU Pharmaceutical

6% 2.2 4.7% 2.6 5.5% 2.8 5.7% Overseas Business 5.1 12.5% 6.4 15.8% 8.1 17.5% 9.9 20.3% 10.9 22.4% Others 0.5 1.2% 2.0 5.0% 2.0 4.4% 2.2 4.7% 1.4 2.9% ＊A new accounting standard for revenue recognitio...

Ltd. Launch and Distribution of “MIEr for ImageFS” Senju Pharmaceutical Co., Ltd., hereby announces the commercial launch and distribution of “MIEr for ImageFS” in Japan. MIEr for ImageFS can sharpen ...